CopyFind
Gracip 250mg Tablet
medicine 📍 IN

Gracip 250mg Tablet

28,00 ₹

Analogs of Gracip 250mg Tablet

Find cheaper analogs and generic equivalents for Gracip 250mg Tablet.

Ingredients

Substanță activă: Ciprofloxacin


Prezentare produs

About Gracip

Gracip is a medication containing the active ingredient Ciprofloxacin, classified as Fluoroquinolone antibiotic. Ciprofloxacin, sold under the brand name Cipro among others, is a fluoroquinolone antibiotic used to treat a number of bacterial infections. This includes bone and joint infections, intra-abdominal infections, certain types of infectious diarrhea, respiratory tract infections, skin infections, typhoid fever, and urina….

Key Benefits & Uses

  • Used for: INDICATIONS AND USAGE Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Ciprofloxacin, the active ingredient in Gracip, belongs to the Fluoroquinolone antibiotic class. INDICATIONS AND USAGE Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Gracip. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Gracip for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Gracip 250mg Tablet.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.